Advisory Alpha, LLC Biogen Inc. Transaction History

Advisory Alpha, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $2,835 - $4,267	-12 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$264.77 - $305.71 $3,177 - $3,668	12 New	12 $286,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $22,762 - $30,144	-88 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $12,367 - $15,687	-46 Reduced 34.33%	88 $25.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $22,446 - $31,015	102 Added 318.75%	134 $39.4 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $6,958 - $7,804	32 New	32 $7,000
Q2 2019 Aug 16, 2019	SELL	$219.29 - $241.72 $2,631 - $2,900	-12 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $2,600 - $4,067	12 New	12 $0

993

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.